Should age determine hypertension management? Recommendations from current guidelines

Area of Science:

• Cardiology
• Gerontology
• Public Health

Background:

• Age is a primary risk factor for cardiovascular disease (CVD).
• Systolic blood pressure (BP) is continuously related to CVD risk across the lifespan.
• Current hypertension guidelines often use dichotomized age groups (e.g., 55-60 years), potentially oversimplifying risk assessment.

Purpose of the Study:

• To critically evaluate the scientific evidence behind age-based dichotomies in hypertension management.
• To compare and contrast current U.S., European, and Canadian hypertension practice guidelines regarding age.
• To explore expert opinions and their influence on diagnostic thresholds and pharmacologic choices in hypertension.

Main Methods:

• Review and analysis of existing international hypertension practice guidelines (U.S., European, Canadian).
• Examination of the scientific literature supporting age-specific recommendations in hypertension.
• Synthesis of editorial commentaries offering diverse perspectives on age and hypertension management.

Main Results:

• Significant differences exist among U.S., European, and Canadian guidelines concerning age-related hypertension thresholds and treatment.
• Current age-based recommendations in some guidelines lack direct scientific evidence and rely heavily on expert opinion.
• The value and certainty of expert opinion in guiding age-specific hypertension management remain questionable.

Conclusions:

• Arbitrary age cutoffs in hypertension guidelines may not accurately reflect continuous risk.
• There is a need for evidence-based approaches to incorporate age into hypertension diagnosis and treatment strategies.
• Further research and critical appraisal of expert opinion are necessary to refine age-specific hypertension care.